SEC Form 4 · accession 0001033905-17-000004
LUMINEX CORP · LMNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tadd S. Lazarus
Officer — SVP, Chief Medical Officer
Period of report
Jan 3, 2017
Accepted (ET)
Jan 5, 2017 · 9:38 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001033905
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 3, 2017 | A | 9,803 | $0.00 | A | 9,803 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right To Buy)F1 | $20.40 | Jan 3, 2017 | A | 23,949 | A | Oct 30, 2019 | Jan 3, 2024 | Common Stock | 23,949 | 23,949 | D |
Explanation of responses
- F1Option and Restricted stock grants described in this Form 4 are scheduled to vest 50% on first anniversary of the reporting owner's hire date, 25% on second anniversary of the reporting owner's hire date, and 25% on the third anniversary of the reporting owner's hire date.